Journal
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 20, Issue 11, Pages 2505-+Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2022.04.045
Keywords
Artificial Intelligence; Optical Diagnosis; Leave in Situ; Resect and Discard; Diminutive Polyps; Colorectal Polyps; Colonoscopy; Machine Learning; Virtual Chromoendoscopy; Polyp Characterization; Colorectal Cancer Screening
Categories
Ask authors/readers for more resources
This study demonstrates that artificial intelligence (AI) exceeds the required benchmarks for the optical diagnosis of colorectal polyps. AI could help implement cost-saving strategies in colonoscopy by reducing the burden of polypectomy and/or pathology.
BACKGROUND & AIMS: Artificial Intelligence (AI) could support cost-saving strategies for colonoscopy because of its accuracy in the optical diagnosis of colorectal polyps. However, AI must meet predefined criteria to be implemented in clinical settings. METHODS: An approved computer-aided diagnosis (CADx) module for differentiating between adenoma and nonadenoma in unmagnified white-light colonoscopy was used in a consecutive series of colonoscopies. For each polyp, CADx output and subsequent endoscopist diagnosis with advanced imaging were matched against the histology gold standard. The primary outcome was the negative predictive value (NPV) of CADx for adenomatous histology for 5-mm pound rectosigmoid lesions. We also calculated the NPV for AI-assisted endoscopist predictions, and agreement between CADx and histology-based postpolypectomy surveillance intervals according to European and American guidelines. RESULTS: Overall, 544 polyps were removed in 162 patients, of which 295 (54.2%) were 5-mm pound rectosigmoid histologically verified lesions. CADx diagnosis was feasible in 291 of 295 (98.6%), and the NPV for 5-mm pound rectosigmoid lesions was 97.6% (95% CI, 94.1%-99.1%). There were 242 of 295 (82%) lesions that were amenable for a leave-in-situ strategy. Based on CADx output, 212 of 544 (39%) would be amenable to a resect-and-discard strategy, resulting in a 95.6% (95% CI, 90.8%-98.0%) and 95.9% (95% CI, 89.8%-98.4%) agreement between CADx- and histology-based surveillance intervals according to European and American guidelines, respectively. A similar NPV (97.6%; 95% CI, 94.8%-99.1%) for 5-mm pound rectosigmoids was achieved by AI-assisted endoscopists assessing polyps with electronic chromoendoscopy, with a CADx-concordant diagnosis in 97.2% of cases. CONCLUSIONS: In this study, CADx without advanced imaging exceeded the benchmarks required for optical diagnosis of colorectal polyps. CADx could help implement cost-saving strategies in colonoscopy by reducing the burden of polypectomy and/or pathology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available